BioSpace News Archive

Marengo Therapeutics, Inc. today announced the appointment of Ke Liu, M.D., Ph.D., as Chief Development Officer, as well as Bruce Chabner, M.D., as Senior Strategic Advisor.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it has completed the divestiture of Sunosi ® (solriamfetol) in the U.S. to Axsome Therapeutics, Inc. (Nasdaq: AXSM).

LENSAR, Inc. today announced financial results for the quarter ended March 31, 2022 and provided an update on operational initiatives.

908 Devices Inc. today announced updates to its MX908 handheld mass spec device, adding new capabilities to streamline workflows and improve field safety for first responders.

Exicure, Inc. today announced a poster presentation at TIDES USA 2022, May 9-12, 2022.

AN2 Therapeutics, Inc. today announced the appointment of Maggie FitzPatrick to its Board of Directors.

Genenta Science announces the appointment of Tim Obara, a highly experienced commercial healthcare executive, as Vice President Business Development.

VectivBio Holding AG announced that Luca Santarelli, M.D., Ph.D., Founder and Chief Executive Officer of VectivBio, will participate in a fireside chat at the Bank of America 2022 Healthcare Conference in Las Vegas, NV.

Mind Medicine today announced that it will host its earnings call on Monday, May 16, 2022 , at 8:30 a.m. EDT to discuss its financial results for the quarter ended March 31, 2022 and provide a business update.

Biohaven Pharmaceutical Holding Company Ltd. plans to hold its upcoming first quarter 2022 earnings call and webcast, reporting financial results for the quarter ended March 31, 2022, and provide a review of recent accomplishments and anticipated upcoming milestones, on Wednesday, May 11, 2022 at 8:30 a.m. ET.